Michael J. Allegrezza

2.2k total citations
18 papers, 1.4k citations indexed

About

Michael J. Allegrezza is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael J. Allegrezza has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Michael J. Allegrezza's work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Michael J. Allegrezza is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Michael J. Allegrezza collaborates with scholars based in United States and Argentina. Michael J. Allegrezza's co-authors include José R. Conejo-García, Nikolaos Svoronos, Melanie R. Rutkowski, Alfredo Perales‐Puchalt, Rugang Zhang, Jenny Nguyen, Amelia J. Tesone, Julia Tchou, Tom L. Stephen and Hengrui Zhu and has published in prestigious journals such as Immunity, The Journal of Immunology and Cancer Cell.

In The Last Decade

Michael J. Allegrezza

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Allegrezza United States 15 737 707 641 124 109 18 1.4k
Nikolaos Svoronos United States 17 806 1.1× 784 1.1× 707 1.1× 113 0.9× 122 1.1× 21 1.6k
Quanli Gao China 18 834 1.1× 582 0.8× 652 1.0× 159 1.3× 209 1.9× 67 1.5k
Priscilla S. Redd United States 15 553 0.8× 617 0.9× 444 0.7× 209 1.7× 189 1.7× 27 1.2k
Dalam Ly Canada 18 477 0.6× 913 1.3× 348 0.5× 147 1.2× 180 1.7× 30 1.4k
Chunwan Lu United States 21 801 1.1× 858 1.2× 726 1.1× 339 2.7× 258 2.4× 41 1.8k
Hannah M. Knochelmann United States 14 649 0.9× 542 0.8× 288 0.4× 113 0.9× 126 1.2× 28 1.1k
Behzad Rowshanravan United Kingdom 7 612 0.8× 647 0.9× 229 0.4× 85 0.7× 166 1.5× 9 1.1k
Takayuki Ohkuri Japan 22 976 1.3× 1.5k 2.1× 583 0.9× 131 1.1× 106 1.0× 56 2.0k
Leonardo Mirandola United States 20 439 0.6× 512 0.7× 606 0.9× 98 0.8× 51 0.5× 58 1.1k
Nadira Delhem France 20 277 0.4× 540 0.8× 331 0.5× 162 1.3× 110 1.0× 41 1.1k

Countries citing papers authored by Michael J. Allegrezza

Since Specialization
Citations

This map shows the geographic impact of Michael J. Allegrezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Allegrezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Allegrezza more than expected).

Fields of papers citing papers by Michael J. Allegrezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Allegrezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Allegrezza. The network helps show where Michael J. Allegrezza may publish in the future.

Co-authorship network of co-authors of Michael J. Allegrezza

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Allegrezza. A scholar is included among the top collaborators of Michael J. Allegrezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Allegrezza. Michael J. Allegrezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rossi, Fiorella, et al.. (2022). Next Generation Natural Killer Cells for Cancer Immunotherapy. Frontiers in Immunology. 13. 886429–886429. 23 indexed citations
2.
Perales‐Puchalt, Alfredo, Kyle K. Payne, Nikolaos Svoronos, et al.. (2018). Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. Journal of Leukocyte Biology. 103(5). 799–805. 70 indexed citations
3.
Stephen, Tom L., Kyle K. Payne, Ricardo A. Chaurio, et al.. (2017). SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells. Immunity. 46(1). 51–64. 115 indexed citations
4.
Villarreal, Daniel O., Michael J. Allegrezza, Melissa Smith, et al.. (2017). Targeting of CD122 enhances antitumor immunity by altering the tumor immune environment. Oncotarget. 8(65). 109151–109160. 12 indexed citations
5.
Svoronos, Nikolaos, Alfredo Perales‐Puchalt, Michael J. Allegrezza, et al.. (2016). Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells. Cancer Discovery. 7(1). 72–85. 152 indexed citations
6.
Perales‐Puchalt, Alfredo, Nikolaos Svoronos, Melanie R. Rutkowski, et al.. (2016). Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. Clinical Cancer Research. 23(2). 441–453. 82 indexed citations
7.
Zhu, Hengrui, Fee Bengsch, Nikolaos Svoronos, et al.. (2016). BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. Cell Reports. 16(11). 2829–2837. 343 indexed citations
8.
Sheen, Mee Rie, Jonathan D. Marotti, Michael J. Allegrezza, et al.. (2016). Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 5(10). e267–e267. 29 indexed citations
9.
Tesone, Amelia J., Melanie R. Rutkowski, Eva Brencicova, et al.. (2016). Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. Cell Reports. 14(7). 1774–1786. 86 indexed citations
10.
Allegrezza, Michael J. & José R. Conejo-García. (2016). Targeted Therapy and Immunosuppression in the Tumor Microenvironment. Trends in cancer. 3(1). 19–27. 57 indexed citations
11.
Allegrezza, Michael J., Nikolaos Svoronos, Alfredo Perales‐Puchalt, et al.. (2016). MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity. The Journal of Immunology. 196(1_Supplement). 74.5–74.5. 1 indexed citations
12.
Allegrezza, Michael J., Melanie R. Rutkowski, Tom L. Stephen, et al.. (2016). IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors. Cancer Research. 76(9). 2561–2572. 28 indexed citations
13.
Allegrezza, Michael J., Melanie R. Rutkowski, Tom L. Stephen, et al.. (2016). Trametinib Drives T-cell–Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis. Cancer Research. 76(21). 6253–6265. 43 indexed citations
14.
Stephen, Tom L., Melanie R. Rutkowski, Michael J. Allegrezza, et al.. (2014). Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression. Immunity. 41(3). 427–439. 92 indexed citations
15.
Rutkowski, Melanie R., Tom L. Stephen, Nikolaos Svoronos, et al.. (2014). Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation. Cancer Cell. 27(1). 27–40. 237 indexed citations
16.
Rutkowski, Melanie R., Michael J. Allegrezza, Nikolaos Svoronos, et al.. (2014). Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer. Journal of Visualized Experiments. 21 indexed citations
17.
Rutkowski, Melanie R., Michael J. Allegrezza, Nikolaos Svoronos, et al.. (2014). Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer. Journal of Visualized Experiments. 8 indexed citations
18.
Tesone, Amelia J., Nikolaos Svoronos, Michael J. Allegrezza, & José R. Conejo-García. (2013). Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer. Frontiers in Immunology. 4. 435–435. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolaos Svoronos Breakdown of academic impact, for papers by Quanli Gao Breakdown of academic impact, for papers by Priscilla S. Redd Breakdown of academic impact, for papers by Dalam Ly Breakdown of academic impact, for papers by Chunwan Lu Breakdown of academic impact, for papers by Hannah M. Knochelmann Breakdown of academic impact, for papers by Behzad Rowshanravan Breakdown of academic impact, for papers by Takayuki Ohkuri Breakdown of academic impact, for papers by Leonardo Mirandola Breakdown of academic impact, for papers by Nadira Delhem
Rankless by CCL
2026